Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Operating Expenses | 9,134 | 8,635 | 7,419 | 7,313 | 5,119 |
| Operating Income | -9,134 | -8,635 | -7,419 | -7,313 | -5,119 |
| Interest Expense | 18 | 0 | 0 | 0 | 0 |
| Other Income | 134 | 164 | 215 | 238 | 232 |
| Pre-tax Income | -9,018 | -8,471 | -7,204 | -7,075 | -4,887 |
| Net Income Continuous | -9,018 | -8,471 | -7,204 | -7,075 | -4,887 |
| Net Income | $-9,018 | $-8,471 | $-7,204 | $-7,075 | $-4,887 |
| EPS Basic Total Ops | -9.12 | -8.64 | -7.36 | -7.20 | -4.96 |
| EPS Basic Continuous Ops | -9.16 | -8.65 | -7.36 | -7.09 | -5.00 |
| EPS Diluted Total Ops | -9.12 | -8.64 | -7.36 | -7.20 | -4.96 |
| EPS Diluted Continuous Ops | -9.16 | -8.65 | -7.36 | -7.09 | -5.00 |
| EBITDA(a) | $-9,038 | $-8,550 | $-7,382 | $-7,305 | $-5,112 |